Exit Accutane: Derms' reactions mixed as Roche pulls long-standing remedy
Publish date: August 1, 2009
John Jesitus
John Jesitus
Dermatologists' reactions to Hoffman-La Roche's decision to discontinue its once-popular acne drug Accutane (isotretinoin) run the gamut. Some express disappointment or surprise; others marvel that the drug survived as long as it did.

